News

FDA Commissioner Marty Makary: Starting Process To Schedule "7-Hydroxymitragynine" Kratom Extract As Dangerous, Illegal Opioid

FDA Commissioner Marty Makary said at a press conference Tuesday that the federal government is beginning to process to ...

FDA Commissioner Makary: Ban Targets Synthetic Concentrated 7-OH, Not Naturally Occurring Trace Amounts

FDA Commissioner Marty Makary said at a press conference Tuesday that scheduling "7-Hydroxymitragynine" (7-OH) kratom extract ...
STAT1h

Vinay Prasad, a powerful FDA official, departs after controversy over rare disease drug

Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial ...

FDA Warns Dangers of Drug “7-OH”

HHS Sec. Robert F. Kennedy, Jr. and Sen. Markwayne Mullin (R-OK), along with FDA Commissioner Dr. Marty Makary, announce new ...

FDA recommends 7-OH compound found in vapes be controlled

The U.S. Food and Drug administration is recommending the scheduling of the 7-OH compound as a controlled substance because ...
STAT19h

How the FDA can score quick wins on transparency

Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...

American Kratom Association Praises Secretary Kennedy and Commissioner Makary for Bold Action to Recommend Scheduling of Dangerous 7-OH Products

Secretary Kennedy and Commissioner Makary have shown exceptional leadership in confronting one of the most urgent public ...
The Hill on MSN9h

FDA calls for illicit drug scheduling of high-dose kratom plant extract 7-OH

The Trump administration is recommending that a compound called 7-OH be scheduled as an illicit drug, Food and Drug Administration Commissioner Marty Makary announced Tuesday. The compound is a ...

100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar

Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and ...
Opinion

FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.
Opinion

When accepting or rejecting new drugs, the FDA will be transparent

‘Drug decision letters’ are being made public — which is good for manufacturers and patients.